Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 687-694 , October 2008

Correlation Between NT-Pro BNP Levels and Left Ventricular Wall Stress, Sphericity Index and Extent of Myocardial Damage: A Magnetic Resonance Imaging Study

  • Rungroj Krittayaphong, MD

      Affiliations

    • Department of Medicine, Division of Cardiology, Siriraj Hospital, Bangkok, Thailand
    • Corresponding Author InformationReprint requests: Rungroj Krittayaphong, MD, Division of Cardiology, Department of Medicine, Siriraj Hospital, Bangkok 10700, Thailand.
    • ,
  • Thananya Boonyasirinant, MD

      Affiliations

    • Department of Medicine, Division of Cardiology, Siriraj Hospital, Bangkok, Thailand
    • ,
  • Pairash Saiviroonporn, PhD

      Affiliations

    • Department of Radiology, Division of Cardiology, Siriraj Hospital, Bangkok, Thailand
    • ,
  • Prajak Thanapiboonpol, RT

      Affiliations

    • Her Majesty Cardiac Center, Division of Cardiology, Siriraj Hospital, Bangkok, Thailand
    • ,
  • Supaporn Nakyen, RT

      Affiliations

    • Her Majesty Cardiac Center, Division of Cardiology, Siriraj Hospital, Bangkok, Thailand
    • ,
  • Suthipol Udompunturak, MS (APPLIED BIOSTAT)

      Affiliations

    • Department of Research Promotion, Division of Cardiology, Siriraj Hospital, Bangkok, Thailand

Received 1 February 2008 ,Revised 11 April 2008 ,Accepted 6 May 2008.

References 

  1. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet. 2006;367:356–367
  2. McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005;365:1877–1889
  3. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161–167
  4. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:1115–1140
  5. Tang WH, Francis GS, Morrow DA, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation. 2007;116:e99–e109
  6. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362:316–322
  7. Das SR, Drazner MH, Dries DL, et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation. 2005;112:2163–2168
  8. Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J. 2003;24:1710–1718
  9. Miller WL, Hartman KA, Burritt MF, et al. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation. 2007;116:249–257
  10. Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol. 2007;49:1733–1739
  11. Bellenger NG, Burgess MI, Ray SG, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?. Eur Heart J. 2000;21:1387–1396
  12. Wagner A, Mahrholdt H, Thomson L, et al. Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement. J Am Coll Cardiol. 2006;47:2027–2033
  13. Judd RM, Wagner A, Rehwald WG, Albert T, Kim RJ. Technology insight: assessment of myocardial viability by delayed-enhancement magnetic resonance imaging. Nat Clin Pract Cardiovasc Med. 2005;2:150–158
  14. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969
  15. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  16. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S. The electrocardiogram in population studies. A classification system. Circulation. 1960;21:1160–1175
  17. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374–379
  18. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539–542
  19. Otsuji Y, Kumanohoso T, Yoshifuku S, et al. Isolated annular dilation does not usually cause important functional mitral regurgitation: comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy. J Am Coll Cardiol. 2002;39:1651–1656
  20. Giga V, Ostojic M, Vujisic-Tesic B, et al. Exercise-induced changes in mitral regurgitation in patients with prior myocardial infarction and left ventricular dysfunction: relation to mitral deformation and left ventricular function and shape. Eur Heart J. 2005;26:1860–1865
  21. Douglas PS, Morrow R, Ioli A, Reichek N. Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1989;13:311–315
  22. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362:777–781
  23. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81:1161–1172
  24. Feigenbaum H. Evaluation of systolic and diastolic function of the left ventricle. In:  Feigenbaum H,  Armstrong W,  Ryan T editor. Feigenbaum's echocardiography. 6th ed.. Philadelphia: Lippincott Williams & Wilkins; 2005;p. 138–180
  25. Cochet A, Zeller M, Cottin Y, et al. The extent of myocardial damage assessed by contrast-enhanced MRI is a major determinant of N-BNP concentration after myocardial infarction. Eur J Heart Fail. 2004;6:555–560
  26. Liang F, O'Rear J, Schellenberger U, et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol. 2007;49:1071–1078
  27. Mehra MR, Uber PA, Park MH, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol. 2004;43:1590–1595
  28. Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J. 2006;27:839–845
  29. Watanabe S, Shite J, Takaoka H, et al. Myocardial stiffness is an important determinant of the plasma brain natriuretic peptide concentration in patients with both diastolic and systolic heart failure. Eur Heart J. 2006;27:832–838
  30. Iwanaga Y, Nishi I, Furuichi S, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol. 2006;47:742–748
  31. Tang WH, Girod JP, Lee MJ, et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation. 2003;108:2964–2966

 Funded by Siriraj Grant for Research Development, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

PII: S1071-9164(08)00166-8

doi: 10.1016/j.cardfail.2008.05.002

Journal of Cardiac Failure
Volume 14, Issue 8 , Pages 687-694 , October 2008

Article Tools

* Image Usage & Resolution